MedTrace Logo

Recurrent Glomerulonephritis After Renal Transplantation

NCT02700516 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 360

Last updated 2016-04-05

No results posted yet for this study

Summary

Glomerulonephritis (GN) is the leading cause of end-stage renal disease in 30% to 50% of patients who receive a renal transplant. The exact prevalence of either recurrent or de novo GN is unknown since a considerable number of patients never undergo allograft biopsy, leaving GN underdiagnosed. The aim of this study is to evaluate the effects of recurrent GN on the prevalence, risk factors, clinicopathological features, and outcome of renal transplant recipients.

Conditions

Sponsors & Collaborators

  • Istanbul University

    lead OTHER

Principal Investigators

  • Yasar Caliskan, MD · Division of Nephrology, Department of Internal Medicine, Istanbul Faculty of Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-03-31
Completion
2016-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02700516 on ClinicalTrials.gov